Physician profile
Katherine E Lewing
NPI 1003536673
$847.60
in general payments reported to CMS, 2019-2025
16 companies · $734 in 2025
The $734 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $33.60 · 2024: $80.03 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $185.73 | 2025 | |
| Axsome Therapeutics, INC. | $127.76 | 2025 | Auvelity |
| Astrazeneca Pharmaceuticals LP | $113.60 | 2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $69.20 | 2025 | Mounjaro, Zepbound |
| Kowa Pharmaceuticals America, INC. | $48.09 | 2025 | Zoryve |
| Otsuka America Pharmaceutical, INC. | $47.53 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $36.65 | 2023-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Novo Nordisk INC | $36.52 | 2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $34.81 | 2024-2025 | |
| Shield Therapeutics INC | $28.55 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $27.96 | 2024 | Kristalose |
| Bayer Healthcare Pharmaceuticals INC. | $22.32 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.12 | 2025 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.25 | 2025 | Caplyta |
| Phadia US INC. | $16.54 | 2024 | Immunocap |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $13.97 | 2023 | Karbinal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Lewing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.